Pages that link to "Q35200033"
Jump to navigation
Jump to search
The following pages link to PPARgamma and metabolism: insights from the study of human genetic variants (Q35200033):
Displaying 26 items.
- Alzheimer's disease and type 2 diabetes via chronic inflammatory mechanisms (Q28086892) (← links)
- Effect of plant extracts on H2O2-induced inflammatory gene expression in macrophages. (Q33930022) (← links)
- An emerging role for bromodomain-containing proteins in chromatin regulation and transcriptional control of adipogenesis (Q34037337) (← links)
- Effects of PPARs agonists on cardiac metabolism in littermate and cardiomyocyte-specific PPAR-γ-knockout (CM-PGKO) mice (Q34259900) (← links)
- The Pro12Ala polymorphism in the peroxisome proliferator-activated receptor gamma-2 gene (PPARγ2) is associated with increased risk of coronary artery disease: a meta-analysis (Q34541672) (← links)
- Effects of sodium butyrate and its synthetic amide derivative on liver inflammation and glucose tolerance in an animal model of steatosis induced by high fat diet. (Q34827887) (← links)
- Obesity and breast cancer: the roles of peroxisome proliferator-activated receptor-γ and plasminogen activator inhibitor-1 (Q34996841) (← links)
- Elevated atherosclerosis-related gene expression, monocyte activation and microparticle-release are related to increased lipoprotein-associated oxidative stress in familial hypercholesterolemia (Q35391967) (← links)
- The metabolic syndrome: a crossroad for genotype-phenotype associations in atherosclerosis (Q35739803) (← links)
- Renal tubular transport and the genetic basis of hypertensive disease (Q36175870) (← links)
- Exendin-4 Inhibits Hepatic Lipogenesis by Increasing β-Catenin Signaling (Q36209797) (← links)
- Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review (Q37014196) (← links)
- PPARγ2 polymorphism and human health (Q37159796) (← links)
- Changes in bone biological markers after treatment of Iranian diabetic patients with pioglitazone: No relation to polymorphism of PPAR-γ (Pro12Ala). (Q37222124) (← links)
- PPARs as new therapeutic targets for the treatment of cerebral ischemia/reperfusion injury (Q37362740) (← links)
- Regulation of the mucosal phenotype in dendritic cells by PPARγ: role of tissue microenvironment (Q37581433) (← links)
- Genetic polymorphisms associated with overweight and obesity in uncontrolled Type 2 diabetes mellitus (Q38783258) (← links)
- Eicosapentaenoic acid (20:5 n-3) increases fatty acid and glucose uptake in cultured human skeletal muscle cells (Q42486772) (← links)
- Sea cucumber and blue mussel: new sources of phospholipid enriched omega-3 fatty acids with a potential role in 3T3-L1 adipocyte metabolism (Q42834172) (← links)
- Identification of genes contributing to the obese yellow Avy phenotype: caloric restriction, genotype, diet x genotype interactions (Q46207304) (← links)
- Peroxisome proliferator-activated receptor-gamma Pro12Ala polymorphism is associated with the susceptibility to ischemic stroke in Taeeumin classified by Sasang medicine (Q47579439) (← links)
- Associations between C1431T and Pro12Ala variants of PPARγ gene and their haplotypes with susceptibility to metabolic syndrome in an Iranian population. (Q48892922) (← links)
- Recent advances on the circadian gene PER2 and metabolic rhythm of lactation of mammary gland. (Q55091639) (← links)
- Butyrate Protects Mice Against Methionine-Choline-Deficient Diet-Induced Non-alcoholic Steatohepatitis by Improving Gut Barrier Function, Attenuating Inflammation and Reducing Endotoxin Levels (Q58728222) (← links)
- Acute effect of rosiglitazone on relaxation responses in hypercholesterolemic corpus cavernosum (Q89090570) (← links)
- Long non-coding RNA HAGLROS regulates lipid metabolism reprogramming in intrahepatic cholangiocarcinoma via the mTOR signaling pathway (Q95646186) (← links)